Truist Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Truist Financial's AMRX Position: Q3 2026 in Review
Truist Financial increased its Amneal Pharmaceuticals (AMRX) stake by 12% in Q3 2026, buying an estimated $95.7K and bringing the position to 49,536 shares worth $998K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.
Truist Financial first reported a position in AMRX in Q4 2019 and has held it in 17 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Truist Financial held 49,536 shares of Amneal Pharmaceuticals worth $998K as of Q3 2026.
- Truist Financial bought 5,314 Amneal Pharmaceuticals shares in Q3 2026, an estimated $95.7K.
- Amneal Pharmaceuticals made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #1772 holding.
- Truist Financial first reported a position in Amneal Pharmaceuticals in Q4 2019 and has held it in 17 quarters since.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.